January 22nd 2025
Caryn Fenner and Petro Terblanche explain how CEPI’s $6.2 million grant will advance Afrigen’s mRNA vaccine for Rift Valley fever through preclinical and Phase I trials in Africa.
Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Addressing Racial Disparities in Multiple Myeloma: Forging a Path Towards Health Equity in Clinical Trials and Everyday Practice
View More
New Drugs, Vaccines Continue to Advance in the Global Fight Against MERS-CoV: Public Health Watch
May 23rd 2018The virus associated with the Middle East may or may not pose a threat to the United States, but researchers here are still working hard to find treatments and preventative vaccines.
Read More
Preventing Emerging Infectious Disease Epidemics: Nipah R&D Roadmap
May 17th 2018In the wake of the Ebola epidemic in West Africa, the World Health Organization is working with the Center for Infectious Disease Research and Policy and the Wellcome Trust to create research & development roadmaps for priority diseases, such as Nipah virus.
Read More
Novartis to Invest $100 Million in Malaria Treatment Research
April 30th 2018The pharmaceutical giant will also launch a program committed to equitable pricing in malaria-endemic countries for new treatments along with expanding pediatric treatment availability and work to strengthen health care systems in 4 African nations.
Read More
New Findings on Zika in Semen May Change Recommendations on Preventing Sexual Transmission
April 26th 2018A recent study sheds light on how long Zika virus can be transmitted through semen following infection, while another study assessed the side effects of Zika infection on infants with post-natal exposure.
Read More